Drug Approval | September 28, 2024
FDA approves Bristol Myers Squibb’s Cobenfy
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Developed in consultation with clinicians and patients for an enhanced user experience
Potential of Ayurveda’s contribution in global health system through various innovative practices
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
The company will also share results in two additional posters for deuruxolitinib
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Subscribe To Our Newsletter & Stay Updated
